HoSeobBaeMD
Gastroenterology • Los Angeles, CAAdvanced Endoscopic Interventional, Hepatology & Liver Transplantation
Physician
Dr. Bae is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
520 S Virgil Ave Ste 202
Los Angeles, CA 90020Phone+1 213-368-0360Fax+1 213-368-0976
Summary
- Ho Bae, MD, is a seasoned Gastroenterologist based in Los Angeles, CA, with subspecialties in Advanced Endoscopic Interventional, Hepatology & Liver Transplantation. Having completed both his residency in Internal Medicine at the University of Southern California/LAC+USC Medical Center and fellowship in Gastroenterology at UCLA David Geffen School of Medicine/UCLA Medical Center, Dr. Bae's expertise lies in hepatology and transplant hepatology. He has published numerous influential articles in field-related journals and has contributions in several clinical trials primarily focusing on Hepatitis B virus. In recognition of his industry contributions, he has been awarded with the CMS Meaningful Use Stage 1 Certification from Aprima EHR, Aprima Medical Software, Inc. in 2012-2014.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1998 - 2001
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1994 - 1997
Loma Linda University School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1996 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Aprima EHR, Aprima Medical Software, Inc., 2012-2014
Clinical Trials
- Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients Start of enrollment: 2010 Sep 01
- Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment Start of enrollment: 2012 Oct 01
Publications & Presentations
PubMed
- 83 citationsSwitching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase ...Pietro Lampertico, Maria Buti, Scott Fung, Sang Hoon Ahn, Wan-Long Chuang
The Lancet. Gastroenterology & Hepatology. 2020-05-01 - 247 citations96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infectionKosh Agarwal, Maurizia Rossana Brunetto, Wai-Kay Seto, Young-Suk Lim, Scott Fung
Journal of Hepatology. 2018-04-01 - 22 citationsSafety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection.Mark S Sulkowski, Kosh Agarwal, Xiaoli Ma, Tuan T Nguyen, Eugene R Schiff
Journal of Hepatology. 2022-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
